Proposed Information Collection; Request for Comments; Survey: Expenditures Incurred by Recipients of Biomedical Research and Development Awards From the National Institutes of Health (NIH), 24290-24291 [2017-10846]
Download as PDF
24290
Federal Register / Vol. 82, No. 101 / Friday, May 26, 2017 / Notices
Persons with disabilities who require
alternative means of communication for
program information (e.g., Braille, large
print, audiotape, American Sign
Language, etc.) should contact the
responsible Agency or USDA’s TARGET
Center at (202) 720–2600 (voice and
TTY) or contact USDA through the
Federal Relay Service at (800) 877–8339.
Additionally, program information may
be made available in languages other
than English.
To file a program discrimination
complaint, complete the USDA Program
Discrimination Complaint Form, AD–
3027, found online at https://
www.ascr.usda.gov/complaint_filing_
cust.html and at any USDA office or
write a letter addressed to USDA and
provide in the letter all of the
information requested in the form. To
request a copy of the complaint form,
call (866) 632–9992. Submit your
completed form or letter to USDA by:
(1) By mail: U.S. Department of
Agriculture, Office of the Assistant
Secretary for Civil Rights, 1400
Independence Avenue SW.,
Washington, DC 20250–9410;
(2) Fax: (202) 690–7442; or
(3) Email: program.intake@usda.gov.
Persons With Disabilities
Individuals who are deaf, hard of
hearing, or have speech disabilities and
you wish to file either an EEO or
program complaint please contact
USDA through the Federal Relay
Service at (800) 877–8339 or (800) 845–
6136 (in Spanish).
Persons with disabilities who wish to
file a program complaint, please see
information above on how to contact us
by mail directly or by email.
If you require alternative means of
communication for program information
(e.g., Braille, large print, audiotape, etc.)
please contact USDA’s TARGET Center
at (202) 720–2600 (voice and TDD).
Appeal Process
All adverse determinations regarding
applicant eligibility and the awarding of
points as part of the selection process
are appealable pursuant to 7 CFR part
11. Instructions on the appeal process
will be provided at the time an
applicant is notified of the adverse
decision.
In the event the applicant is awarded
a grant that is less than the amount
requested, the applicant will be required
to modify its application to conform to
the reduced amount before execution of
the grant agreement. The Agency
reserves the right to reduce or withdraw
the award if acceptable modifications
are not submitted by the awardee within
15 working days from the date the
VerDate Sep<11>2014
19:14 May 25, 2017
Jkt 241001
request for modification is made. Any
modifications must be within the scope
of the original application.
Dated: May 19, 2017.
Richard A. Davis,
Acting Administrator, Rural Housing Service.
[FR Doc. 2017–10776 Filed 5–25–17; 8:45 am]
BILLING CODE 3410–XV–P
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
[Docket No. 179323306–7306–01]
RIN 0691–XC067
Proposed Information Collection;
Request for Comments; Survey:
Expenditures Incurred by Recipients of
Biomedical Research and
Development Awards From the
National Institutes of Health (NIH)
Bureau of Economic Analysis,
Department of Commerce.
ACTION: Notice; request for comments.
AGENCY:
The Department of
Commerce, as part of its continuing
effort to reduce paperwork and
respondent burden, as required by the
Paperwork Reduction Act of 1995,
invites the general public and other
Federal agencies to comment on this
survey of expenditures incurred by
recipients of biomedical research and
development awards from the NIH.
DATES: Written comments must be
submitted on or before July 25, 2017.
ADDRESSES: Direct all written comments
to Jennifer Jessup, Departmental
Paperwork Clearance Officer,
Department of Commerce, Room 6616,
14th and Constitution Avenue NW.,
Washington, DC 20230, or via email at
PRAcomments@doc.gov.
FOR FURTHER INFORMATION CONTACT:
Jennifer A. Bennett, Chief, Government
Fixed Assets Branch, Government
Division (BE–57), Bureau of Economic
Analysis, U.S. Department of
Commerce, 4600 Silver Hill Rd.,
Washington, DC 20233 via phone at
(301) 278–9769, or via email at
jennifer.bennett@bea.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Abstract
The survey obtains the distribution of
expenditures incurred by recipients of
biomedical research awards from the
National Institutes of Health (NIH) in
order to provide information on how the
NIH award amounts are expended
across several major categories. This
information, along with wage and price
data from other published sources, will
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
be used to generate the Biomedical
Research and Development Price Index
(BRDPI). The Bureau of Economic
Analysis (BEA) develops this index for
NIH under a reimbursable contract. The
BRDPI is an index of prices paid for the
labor, supplies, equipment, and other
inputs required to perform the
biomedical research the NIH supports in
its intramural laboratories and through
its awards to extramural organizations.
The BRDPI is a vital tool for planning
the NIH research budget and analyzing
future NIH programs. A survey of award
recipients is currently the only means
for updating the expenditure category
weights that are used to prepare the
BRDPI.
II. Authority
The Department of Commerce, as part
of its continuing effort to reduce
paperwork and respondent burden
pursuant to the requirements of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3506(c)(2)(A)), invites the general
public and other Federal agencies to
comment on this survey of expenditures
incurred by recipients of biomedical
research and development awards from
the NIH. This survey will be voluntary.
The authority for NIH to collect
information for the BRDPI is provided
in 45 CFR, part 74, subpart C (PostAward Requirements), in which section
74.21 sets forth explicit standards for
grantees in establishing and maintaining
financial management systems and
records, and section 74.53 provides for
the retention of such records, as well as
NIH access to such records.
BEA will administer the survey and
analyze the survey results on behalf of
NIH, through an interagency agreement
between the two agencies. The authority
for the NIH to contract with the
Department of Commerce (DOC) to
make this collection is the Economy Act
(31 U.S.C. 1535 and 1536).
The special studies authority, 15
U.S.C. 1525, permits DOC to provide,
upon the request of any person, firm, or
public or private organization special
studies on matters within DOC’s
authority, including preparing from its
records special compilations, lists,
bulletins, or reports, and furnishing
transcripts or copies of its studies,
compilations and other records. NIH’s
support for this research is consistent
with its duties and authority under 42
U.S.C. 282.
The information provided by the
respondents will be kept confidential
and be used for exclusively statistical
purposes. This pledge of confidentiality
is made under the confidential
information protection provisions of
title V, subtitle A of Public Law 107–
E:\FR\FM\26MYN1.SGM
26MYN1
Federal Register / Vol. 82, No. 101 / Friday, May 26, 2017 / Notices
347. Title V is the Confidential
Information Protection and Statistical
Efficiency Act of 2002 (CIPSEA).
Section 512 (Limitations on Use and
Disclosure of Data and Information) of
CIPSEA provides that data or
information acquired by an agency
under a pledge of confidentiality and for
exclusively statistical purposes shall be
used by officers, employees, or agents of
the agency exclusively for statistical
purposes. Data or information acquired
by an agency under a pledge of
confidentiality for exclusively statistical
purposes shall not be disclosed by an
agency in identifiable form for any use
other than an exclusively statistical
purpose, except with the informed
consent of the respondent.
Responses will be kept confidential
and will not be disclosed in identifiable
form to anyone, other than employees or
agents of BEA or agents of NIH, without
prior written permission of the person
filing the report. By law, each employee
or agent is subject to a jail term of up
to 5 years, a fine of up to $250,000, or
both, for disclosing to the public any
identifiable information that is reported
about a business or institution.
In addition, section 515 of the
Treasury and General Government
Appropriations Act, 2001 (Pub. L. 106–
554, Appendix C, § 515) applies to this
survey. The collection and use of this
information complies with all
applicable information quality
guidelines of the Office of Management
and Budget, DOC, and BEA.
III. Method of Collection
A survey with a cover letter that
includes a brief description of, and
rationale for, the survey will be sent by
email to potential respondents by the
first week of August in 2017, 2018 and
2019. A report of the respondent’s
expenditures of the NIH award amounts,
including NIH awards received as a subrecipient from another institution,
following the proposed format for
expenditure categories included with
the survey form, will be requested to be
completed and submitted online no
later than December 8, which, in most
years, will be approximately 120 days
after mailing. Survey respondents will
be selected on the basis of award levels,
which determine the weight of the
respondents in the biomedical research
and development price index. Potential
respondents will include (1) the top 100
organizations in total awards, which
account for about 77 percent of total
awards; (2) 40 additional organizations
that are not primarily in the ‘‘Research
and Development (R&D) contracts’’
category; and (3) 10 additional
VerDate Sep<11>2014
19:14 May 25, 2017
Jkt 241001
organizations that are primarily in the
‘‘R&D contracts’’ category.
IV. Data
OMB Control Number: 0608–0069.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Universities or other
organizations that are NIH award
recipients.
Estimated Number of Respondents:
120.
Estimated Time per Response: 16
hours, but may vary among respondents
because of differences in institution
structure, size, and complexity.
Estimated Total Annual Burden
Hours: 1,920 hours.
Estimated Total Annual Cost to
Public: $0.
V. Request for Comments
Comments are invited on: (1) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the NIH, including
whether the information has practical
utility; (2) the accuracy of the agency’s
estimate of the burden (including hours
and cost) of the proposed collection of
information; (3) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the request for OMB
approval of this information collection;
they also will become a matter of public
record.
Sheleen Dumas,
Departmental PRA Lead, Office of Chief
Information Officer.
[FR Doc. 2017–10846 Filed 5–25–17; 8:45 am]
DEPARTMENT OF COMMERCE
International Trade Administration
University of California, Riverside, et
al. Notice of Consolidated Decision on
Applications for Duty-Free Entry of
Electron Microscope
This is a decision consolidated
pursuant to Section 6(c) of the
Educational, Scientific, and Cultural
Materials Importation Act of 1966 (Pub.
L. 89–651, as amended by Pub. L. 106–
36; 80 Stat. 897; 15 CFR part 301).
Related records can be viewed between
8:30 a.m. and 5:00 p.m. in Room 3720,
U.S. Department of Commerce, 14th and
Frm 00017
Fmt 4703
Constitution Avenue NW., Washington,
DC.
Docket Number: 16–010. Applicant:
University of California, Riverside,
Riverside, CA 92521. Instrument:
Electron Microscope. Manufacturer: FEI
Company, the Netherlands. Intended
Use: See notice at 81 FR 71702–03,
October 18, 2016.
Docket Number: 16–018. Applicant:
UChicago Argonne, Lemont, IL 60439.
Instrument: Electron Microscope.
Manufacturer: FEI Company, Czech
Republic. Intended Use: See notice at 81
FR 89433–34, December 12, 2016.
Docket Number: 16–022. Applicant:
Regents of the University of Colorado,
Denver, CO 80203. Instrument: Electron
Microscope. Manufacturer: FEI
Company, Brno Czech Republic.
Intended Use: See notice at 81 FR
89433–34, December 12, 2016.
Comments: None received. Decision:
Approved. No instrument of equivalent
scientific value to the foreign
instrument, for such purposes as this
instrument is intended to be used, is
being manufactured in the United States
at the time the instrument was ordered.
Reasons: Each foreign instrument is an
electron microscope and is intended for
research or scientific educational uses
requiring an electron microscope. We
know of no electron microscope, or any
other instrument suited to these
purposes, which was being
manufactured in the United States at the
time of order of each instrument.
Dated: May 22, 2017.
Gregory W. Campbell,
Director, Subsidies Enforcement Office,
Enforcement and Compliance.
[FR Doc. 2017–10874 Filed 5–25–17; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
International Trade Administration
BILLING CODE 3510–EA–P
PO 00000
24291
Sfmt 4703
[C–533–858]
Certain Oil Country Tubular Goods
From India: Rescission of
Countervailing Duty Administrative
Review; 2015
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
is rescinding the administrative review
of the countervailing duty (CVD) order
on certain oil country tubular goods
(OCTG) from India, covering the period
January 1, 2015, through December 31,
2015.
DATES: Effective May 26, 2017.
AGENCY:
E:\FR\FM\26MYN1.SGM
26MYN1
Agencies
[Federal Register Volume 82, Number 101 (Friday, May 26, 2017)]
[Notices]
[Pages 24290-24291]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-10846]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
[Docket No. 179323306-7306-01]
RIN 0691-XC067
Proposed Information Collection; Request for Comments; Survey:
Expenditures Incurred by Recipients of Biomedical Research and
Development Awards From the National Institutes of Health (NIH)
AGENCY: Bureau of Economic Analysis, Department of Commerce.
ACTION: Notice; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Department of Commerce, as part of its continuing effort
to reduce paperwork and respondent burden, as required by the Paperwork
Reduction Act of 1995, invites the general public and other Federal
agencies to comment on this survey of expenditures incurred by
recipients of biomedical research and development awards from the NIH.
DATES: Written comments must be submitted on or before July 25, 2017.
ADDRESSES: Direct all written comments to Jennifer Jessup, Departmental
Paperwork Clearance Officer, Department of Commerce, Room 6616, 14th
and Constitution Avenue NW., Washington, DC 20230, or via email at
PRAcomments@doc.gov.
FOR FURTHER INFORMATION CONTACT: Jennifer A. Bennett, Chief, Government
Fixed Assets Branch, Government Division (BE-57), Bureau of Economic
Analysis, U.S. Department of Commerce, 4600 Silver Hill Rd.,
Washington, DC 20233 via phone at (301) 278-9769, or via email at
jennifer.bennett@bea.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The survey obtains the distribution of expenditures incurred by
recipients of biomedical research awards from the National Institutes
of Health (NIH) in order to provide information on how the NIH award
amounts are expended across several major categories. This information,
along with wage and price data from other published sources, will be
used to generate the Biomedical Research and Development Price Index
(BRDPI). The Bureau of Economic Analysis (BEA) develops this index for
NIH under a reimbursable contract. The BRDPI is an index of prices paid
for the labor, supplies, equipment, and other inputs required to
perform the biomedical research the NIH supports in its intramural
laboratories and through its awards to extramural organizations. The
BRDPI is a vital tool for planning the NIH research budget and
analyzing future NIH programs. A survey of award recipients is
currently the only means for updating the expenditure category weights
that are used to prepare the BRDPI.
II. Authority
The Department of Commerce, as part of its continuing effort to
reduce paperwork and respondent burden pursuant to the requirements of
the Paperwork Reduction Act of 1995 (44 U.S.C. 3506(c)(2)(A)), invites
the general public and other Federal agencies to comment on this survey
of expenditures incurred by recipients of biomedical research and
development awards from the NIH. This survey will be voluntary. The
authority for NIH to collect information for the BRDPI is provided in
45 CFR, part 74, subpart C (Post-Award Requirements), in which section
74.21 sets forth explicit standards for grantees in establishing and
maintaining financial management systems and records, and section 74.53
provides for the retention of such records, as well as NIH access to
such records.
BEA will administer the survey and analyze the survey results on
behalf of NIH, through an interagency agreement between the two
agencies. The authority for the NIH to contract with the Department of
Commerce (DOC) to make this collection is the Economy Act (31 U.S.C.
1535 and 1536).
The special studies authority, 15 U.S.C. 1525, permits DOC to
provide, upon the request of any person, firm, or public or private
organization special studies on matters within DOC's authority,
including preparing from its records special compilations, lists,
bulletins, or reports, and furnishing transcripts or copies of its
studies, compilations and other records. NIH's support for this
research is consistent with its duties and authority under 42 U.S.C.
282.
The information provided by the respondents will be kept
confidential and be used for exclusively statistical purposes. This
pledge of confidentiality is made under the confidential information
protection provisions of title V, subtitle A of Public Law 107-
[[Page 24291]]
347. Title V is the Confidential Information Protection and Statistical
Efficiency Act of 2002 (CIPSEA). Section 512 (Limitations on Use and
Disclosure of Data and Information) of CIPSEA provides that data or
information acquired by an agency under a pledge of confidentiality and
for exclusively statistical purposes shall be used by officers,
employees, or agents of the agency exclusively for statistical
purposes. Data or information acquired by an agency under a pledge of
confidentiality for exclusively statistical purposes shall not be
disclosed by an agency in identifiable form for any use other than an
exclusively statistical purpose, except with the informed consent of
the respondent.
Responses will be kept confidential and will not be disclosed in
identifiable form to anyone, other than employees or agents of BEA or
agents of NIH, without prior written permission of the person filing
the report. By law, each employee or agent is subject to a jail term of
up to 5 years, a fine of up to $250,000, or both, for disclosing to the
public any identifiable information that is reported about a business
or institution.
In addition, section 515 of the Treasury and General Government
Appropriations Act, 2001 (Pub. L. 106-554, Appendix C, Sec. 515)
applies to this survey. The collection and use of this information
complies with all applicable information quality guidelines of the
Office of Management and Budget, DOC, and BEA.
III. Method of Collection
A survey with a cover letter that includes a brief description of,
and rationale for, the survey will be sent by email to potential
respondents by the first week of August in 2017, 2018 and 2019. A
report of the respondent's expenditures of the NIH award amounts,
including NIH awards received as a sub-recipient from another
institution, following the proposed format for expenditure categories
included with the survey form, will be requested to be completed and
submitted online no later than December 8, which, in most years, will
be approximately 120 days after mailing. Survey respondents will be
selected on the basis of award levels, which determine the weight of
the respondents in the biomedical research and development price index.
Potential respondents will include (1) the top 100 organizations in
total awards, which account for about 77 percent of total awards; (2)
40 additional organizations that are not primarily in the ``Research
and Development (R&D) contracts'' category; and (3) 10 additional
organizations that are primarily in the ``R&D contracts'' category.
IV. Data
OMB Control Number: 0608-0069.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Universities or other organizations that are NIH
award recipients.
Estimated Number of Respondents: 120.
Estimated Time per Response: 16 hours, but may vary among
respondents because of differences in institution structure, size, and
complexity.
Estimated Total Annual Burden Hours: 1,920 hours.
Estimated Total Annual Cost to Public: $0.
V. Request for Comments
Comments are invited on: (1) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the NIH, including whether the information has practical utility; (2)
the accuracy of the agency's estimate of the burden (including hours
and cost) of the proposed collection of information; (3) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (4) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the request for OMB approval of this information
collection; they also will become a matter of public record.
Sheleen Dumas,
Departmental PRA Lead, Office of Chief Information Officer.
[FR Doc. 2017-10846 Filed 5-25-17; 8:45 am]
BILLING CODE 3510-EA-P